All News

3 Tips for Getting Comfortable With an Ostomy After GI Cancer Surgery

November 29th 2022

An expert offers three steps that patients can take to become more comfortable and confident with their ostomy after undergoing surgery for gastric cancer.

There Is an Upside to Cancer

November 29th 2022

Cancer made me realize that there is more to life than just work.

What to Know After Receiving a Kidney Cancer Diagnosis: ‘Seek Speciality Care,’ Expert Says

November 29th 2022

In a recent interview with Cancer Horizons®, the medical liaison for KidneyCAN, discussed the basics of kidney cancer and what she thinks patients should know.

Educated Patient® Metastatic Breast Cancer Summit Addressing Unmet Needs Panel: November 12, 2022

November 29th 2022

Watch Dr. Leif Ellisen, Dr. Dejan Juric, Dr. Beverly Moy and Natasha Mmeje answer questions about unmet needs during the CURE Educated Patient Metastatic Breast Cancer Summit.

Motivation for Committing to Wellness While Fighting Cancer

November 28th 2022

For some, sticking to healthy habits can be difficult, but when I was going through cancer, I felt that my life depended on it.

Tools Patients, Survivors and Cancer Caregivers Use to Deal With ‘Scanxiety’

November 28th 2022

CURE® surveyed its audience to see how they cope with “scanxiety,” the anxiety surrounding cancer scans. Here’s what they had to say.

Changing Cancer Clinical Trials Through Collaboration

November 28th 2022

It isn’t enough to say that cancer clinical trials need more diversity and patient support; we must take action.

Metastasis-Directed Therapies May Lead to a Delay in Disease Progression for Some Patients With Prostate Cancer

November 28th 2022

A new study may provide hope that future treatments can delay androgen-deprivation therapy and prolong survival in patients with oligometastatic prostate cancer.

Educated Patient® Metastatic Breast Cancer Summit Addressing Breast Cancer Disparity Presentation: November 12, 2022

November 28th 2022

Watch Dr. Beverly Moy, from Massachusetts General Hospital, discuss addressing breast cancer disparity during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit Addressing Therapeutic Resistance Presentation: November 12, 2022

November 27th 2022

Watch Dr. Dejan Juric, from Massachusetts General Hospital, discuss therapeutic resistance during the CURE Educated Patient Metastatic Breast Cancer Summit.

Educated Patient® Metastatic Breast Cancer Summit HER2 and Triple-Negative Disease Panel: November 12, 2022

November 26th 2022

Watch Dr. Aditya Bardia, Dr. Arielle J. Medford and Dr. Neelima Vidula answer questions about HER2 and triple-negative disease during the CURE Educated Patient Metastatic Breast Cancer Summit.

Forever Forward: My Male Breast Cancer Motto

November 25th 2022

Communication is key with cancer survivorship, especially for rare diseases like male breast cancer.

Cancer Survivor Waits 36 Hours to Meet Houston Astros Player, Armie Hammer’s Father Dies of Cancer and More

November 25th 2022

From a uterine cancer survivor camping out in front of a store to meet the Astros’ Jose Altuve to Michael Armand Hammer’s death from cancer, here’s what’s happening in the cancer space this week.

Educated Patient® Metastatic Breast Cancer Summit Management of Triple Negative Disease Presentation: November 12, 2022

November 25th 2022

Watch Dr. Neelima Vidula, from Massachusetts General Hospital, discuss the management of triple-negative disease during the CURE Educated Patient Metastatic Breast Cancer Summit.

Writing Thank You Letters to My Oncology Team Helped Me Feel Grounded and Grateful

November 24th 2022

After being diagnosed with breast cancer, I wrote thank you letters to my oncology care team which, to my surprise, helped put me at ease.

Educated Patient® Metastatic Breast Cancer Summit: November 12, 2022

November 24th 2022

Watch Dr. Arielle J. Medford, from Dana-Farber Cancer Institute, discuss the management of HER2-positive disease during the CURE® Educated Patient® Metastatic Breast Cancer Summit.

Evaluating Existing and Future Surgical Options for Early-Stage Lung Cancer

November 23rd 2022

As part of its “Speaking Out” video series, Dr. Peter Baik, on behalf of Cancer Treatment Centers of America, discussed how far the space has come with surgical advances, and where it is headed, in treating early-stage lung cancer.

‘Time is of the Essence’ in Decision-Making for Early-Stage Lung Cancer

November 23rd 2022

As part of its “Speaking Out” video series, Dr. Peter Baik, on behalf of Cancer Treatment Centers of America, discussed the importance of timing and decision-making of treatment in early-stage lung cancer.

Expert Addresses Disparities in Lung Cancer Screening, What More Can Be Done

November 23rd 2022

As part of its “Speaking Out” video series, Dr. Peter Baik, on behalf of Cancer Treatment Centers of America, discussed disparities seen in lung cancer screening and what more can be done.

FDA to Expedite Review of Novel Non-Hodgkin Lymphoma Drug

November 23rd 2022

The Food and Drug Administration granted a priority review to epcoritamab for certain patients with large B-cell lymphoma, an aggressive type of blood cancer.

Cancer Survivorship Superstitions: Can a Delayed Mammogram Be Catastrophic?

November 23rd 2022

A routine can feel so comfortable that change is hard. So, when my annual mammogram and cancer checkup was delayed, I tried hard not to sweat the small stuff.

'A Village of People’ May Help Cancer Caregivers Balance Everyday Life

November 23rd 2022

A woman whose husband was diagnosed with ocular melanoma at 28 years old opens up about her experiences navigating the cancer world and her search for a supportive community.

Educated Patient® Metastatic Breast Cancer Summit HR-Positive Disease Panel: November 12, 2022

November 23rd 2022

Watch Dr. Aditya Bardia, Dr. Seth A. Wander and Dr. Laura M. Spring answer questions about HR-positive disease during the CURE Educated Patient Metastatic Breast Cancer Summit.

FDA Approval of Elahere Represents a ‘Step Forward’ for Platinum-Resistant Ovarian Cancer Subset

November 22nd 2022

One expert said that the FDA approval of the antibody-drug conjugate Elahere represents a new treatment option for patients with folate receptor alpha-positive, platinum resistant ovarian cancer.

High Sugar Intake May Lead to Premature Aging in Childhood Cancer Survivors

November 22nd 2022

Childhood cancer survivors who had high daily sugar intake — especially when it came to sweetened beverages — had an increased risk of premature aging-related health complications, according to recent research.

Preparing For a Season of Thanksgiving as a Cancer Survivor

November 22nd 2022

Thanksgiving can be a stressful time for those with cancer, but it doesn’t have to be. I learned that it can also be a time filled with love and joy.

You Are Not Alone: The Sarcoma Alliance as a Patient Advocate

November 22nd 2022

A nonprofit organization aims to connect patients, caregivers and loved ones affected by sarcoma while educating those about the rare cancer.

Educated Patient® Metastatic Breast Cancer Summit Overview of Management of Hormone Receptor-positive Breast Cancer: Third Line and Beyond Presentation: November 12, 2022

November 22nd 2022

Watch Dr. Laura M. Spring, from Massachusetts General Hospital in Boston, discuss treatment in third line and beyond for hormone receptor-positive breast cancer, during the CURE® Educated Patient® Metastatic Breast Cancer Summit.

Finding Support During a Multiple Myeloma Diagnosis

November 21st 2022

As a part of its “Speaking Out” video series, on behalf of the International Myeloma Foundation, CURE® spoke with their vice president of support, Robin Tuohy about the importance of support for patients with multiple myeloma, and their caregivers.

The Basics of Clinical Trials for Patients with Multiple Myeloma

November 21st 2022

As a part of its “Speaking Out” video series, on behalf of the International Myeloma Foundation, CURE® spoke with their chief medical officer, Dr. Joseph Mikhael about clinical trials for patients with multiple myeloma.